Jinhai Medical Technology Ltd. (2225) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

ManpowerGroup Greater China Ltd.

Tongdao Liepin Group

Jinhai Medical Technology Ltd.

South China Vocational Education Group Co., Ltd.

SingAsia Holdings Ltd.

Bamboos Health Care Holdings Ltd.

ETS Group Ltd.

KOS International Holdings Ltd.

Omnibridge Holdings Ltd.

Why is Jinhai Medical Technology Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.47%

Poor long term growth as Net Sales has grown by an annual rate of -0.01% and Operating profit at -261.32% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.05

Flat results in Dec 25

OPERATING CASH FLOW(Y) Lowest at HKD -59.28 MM
RAW MATERIAL COST(Y) Grown by 23.56% (YoY)
INVENTORY TURNOVER RATIO(HY) Lowest at 10.56 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 171.43%, its profits have fallen by -144.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Diversified Commercial Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jinhai Medical Technology Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Jinhai Medical Technology Ltd.

171.43%

1.67

111.73%

Hang Seng Hong Kong

8.76%

0.45

19.63%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.01%

EBIT Growth (5y)

-261.32%

EBIT to Interest (avg)

-1.05

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.10

Sales to Capital Employed (avg)

0.91

Tax Ratio

0.15%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

23.27%

ROE (avg)

0.47%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

65.57

EV to EBIT

-77.97

EV to EBITDA

-93.95

EV to Capital Employed

54.65

EV to Sales

48.59

PEG Ratio

Dividend Yield

ROCE (Latest)

-70.09%

ROE (Latest)

-85.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

NET PROFIT(HY)

Higher at HKD -38.75 MM

CASH AND EQV(HY)

Highest at HKD 222.62 MM

NET SALES(Q)

At HKD 191.95 MM has Grown at 34.48%

PRE-TAX PROFIT(Q)

At HKD -36.41 MM has Grown at 51.25%

-7What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD -59.28 MM

RAW MATERIAL COST(Y)

Grown by 23.56% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 10.56 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.84 times

Here's what is working for Jinhai Medical Technology Ltd.

Net Profit

Higher at HKD -38.75 MM

than preceding 12 month period ended Dec 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Net Sales

At HKD 191.95 MM has Grown at 34.48%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Pre-Tax Profit

At HKD -36.41 MM has Grown at 51.25%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Cash and Eqv

Highest at HKD 222.62 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation

Highest at HKD 23.79 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 23.79 MM has Grown at 490.73%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Jinhai Medical Technology Ltd.

Operating Cash Flow

Lowest at HKD -59.28 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Inventory Turnover Ratio

Lowest at 10.56 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.84 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 23.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales